EC Number | Application | Comment | Organism |
---|---|---|---|
2.4.2.1 | drug development | the enzyme is a target for drug development | Helicobacter pylori |
2.4.2.1 | drug development | differences in specificity between homotrimeric (including human enzyme) and homohexameric PNPs, including various pathogenic organisms, make them interesting potential drug targets | Bos taurus |
2.4.2.1 | drug development | differences in specificity between homotrimeric (including human enzyme) and homohexameric PNPs, including various pathogenic organisms, make them interesting potential drug targets | Escherichia coli |
2.4.2.1 | drug development | differences in specificity between homotrimeric (including human enzyme) and homohexameric PNPs, including various pathogenic organisms, make them interesting potential drug targets | Homo sapiens |
2.4.2.1 | drug development | the enzyme is a target for development of anti-malarial drugs | Plasmodium falciparum |
2.4.2.1 | pharmacology | substrate 6-mercaptopurine-2'-deoxyriboside is of special interest, because, in contrast to a nucleoside, its parent purine is highly cytotoxic and is known as one of the first compounds applied as anti-cancer drugs | Escherichia coli |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.4.2.1 | N243D | site-directed mutagenesis, the mutation in trimeric PNP changes the substrate specificity, making 6-aminopurine nucleosides good substrates | Thermus thermophilus |
2.4.2.1 | N243D | site-directed mutagenesis, the mutation in trimeric PNP changes the substrate specificity, making 6-aminopurine nucleosides good substrates | Bos taurus |
2.4.2.1 | N243D | site-directed mutagenesis, the mutation in trimeric PNP changes the substrate specificity, making 6-aminopurine nucleosides good substrates | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.2.1 | 6-methylformycin A | strng inhibition | Escherichia coli | |
2.4.2.1 | 9-(3-pyridylmethyl)-9-deaza-guanosine | i.e. peldesine or BCX34 | Bos taurus | |
2.4.2.1 | 9-(3-pyridylmethyl)-9-deaza-guanosine | i.e. peldesine or BCX34 | Homo sapiens | |
2.4.2.1 | DADMe-immucillin-G | i.e. forodesine or BCX4945 | Bos taurus | |
2.4.2.1 | DADMe-immucillin-G | i.e. forodesine or BCX4945 | Homo sapiens | |
2.4.2.1 | DADMe-immucillin-G | i.e. forodesine or BCX4945 | Plasmodium falciparum | |
2.4.2.1 | DADMe-immucillin-H | i.e. ulodesine or BCX4208 | Bos taurus | |
2.4.2.1 | DADMe-immucillin-H | i.e. ulodesine or BCX4208 | Homo sapiens | |
2.4.2.1 | DADMe-immucillin-H | i.e. ulodesine or BCX4208 | Plasmodium falciparum | |
2.4.2.1 | DATMe-immucillin-H | - |
Bos taurus | |
2.4.2.1 | DATMe-immucillin-H | - |
Homo sapiens | |
2.4.2.1 | DFPP-DG | - |
Bos taurus | |
2.4.2.1 | DFPP-DG | - |
Homo sapiens | |
2.4.2.1 | Formycin A | an analogue of adenosine | Bos taurus | |
2.4.2.1 | Formycin A | - |
Escherichia coli | |
2.4.2.1 | Formycin A | an analogue of adenosine | Homo sapiens | |
2.4.2.1 | formycin B | structural, 9-deaza-8-aza analogue of inosine | Bos taurus | |
2.4.2.1 | formycin B | structural, 9-deaza-8-aza analogue of inosine | Escherichia coli | |
2.4.2.1 | formycin B | structural, 9-deaza-8-aza analogue of inosine | Homo sapiens | |
2.4.2.1 | immucillin-G | an analogue of guanosine | Bos taurus | |
2.4.2.1 | immucillin-G | an analogue of guanosine | Homo sapiens | |
2.4.2.1 | immucillin-H | i.e. forodesine or BCX1777, an analogue of inosine | Bos taurus | |
2.4.2.1 | immucillin-H | i.e. forodesine or BCX1777, an analogue of inosine | Homo sapiens | |
2.4.2.1 | additional information | formycins are 9-deaza-8-aza-nucleosides and selective inhibitors of hexameric PNPs. 8-Aza-9-deazapurine derivatives as enzyme inhibitors, overview | Escherichia coli | |
2.4.2.1 | additional information | immucillins are potent slow-binding inhibitors, forming rapidly the enzyme/inhibitor collision complex that is characterized by nM enzyme/inhibitor affinity, followed by a slow conformational change leading a tight-binding enzyme/inhibitor complex. Immucilins, like ground-state analogue inhibitors, bind with the stoichiometry of three molecules per enzyme trimer. Another interesting class of PNP inhibitors comprises so-called bisubstrate analogs, represented by purine-alkylphosphonates and difluoromethylene phosphonates, which compete with both PNP substrates, nucleoside and phosphate, and therefore interact with PNP with inhibition constants markedly dependent on inorganic phosphate concentration. 8-aza-9-deazapurine derivatives as enzyme inhibitors, overview | Homo sapiens | |
2.4.2.1 | SerMe-immucillin-H | SerMe-ImmH, uses achiral dihydroxyaminoalcohol seramide as the ribocation mimic | Bos taurus | |
2.4.2.1 | SerMe-immucillin-H | SerMe-ImmH, uses achiral dihydroxyaminoalcohol seramide as the ribocation mimic | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.1 | 1-methyladenosine + phosphate | Escherichia coli | - |
1-methyladenine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | 1-methylguanosine + phosphate | Escherichia coli | - |
1-methylguanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | 6-mercaptopurine-2'-deoxyriboside + phosphate | Escherichia coli | - |
6-mercaptopurine + 2-deoxy-alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | 8-azaguanine + alpha-D-ribose 1-phosphate | Escherichia coli | - |
8-azaguanosine + phosphate | - |
r | |
2.4.2.1 | 8-azaguanosine + phosphate | Escherichia coli | - |
8-azaguanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | 8-azaguanosine + phosphate | Homo sapiens | - |
8-azaguanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | 9-beta-D-arabinosyl-2-fluoroadenine + phosphate | Escherichia coli | i.e. fludarabine | 2-fluoroadenine + beta-D-arabinose 1-phosphate | - |
r | |
2.4.2.1 | adenosine + phosphate | Escherichia coli | - |
adenine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | Thermus thermophilus | - |
guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | Bacillus cereus | - |
guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | Pectobacterium carotovorum | - |
guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | Plasmodium lophurae | - |
guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | Cellulomonas sp. | - |
guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | Bos taurus | - |
guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | Escherichia coli | - |
guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | Plasmodium falciparum | - |
guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | Homo sapiens | - |
guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | Helicobacter pylori | - |
guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | Thermus thermophilus | - |
hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | Bacillus cereus | - |
hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | Pectobacterium carotovorum | - |
hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | Plasmodium lophurae | - |
hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | Cellulomonas sp. | - |
hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | Bos taurus | - |
hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | Escherichia coli | - |
hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | Plasmodium falciparum | - |
hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | Homo sapiens | - |
hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | Helicobacter pylori | - |
hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | nicotinamide riboside + phosphate | Escherichia coli | - |
nicotinamide + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | xanthosine + phosphate | Escherichia coli | - |
xanthine + alpha-D-ribose 1-phosphate | - |
r |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.2.1 | Bacillus cereus | - |
- |
- |
2.4.2.1 | Bos taurus | P55859 | calf | - |
2.4.2.1 | Cellulomonas sp. | P81989 | - |
- |
2.4.2.1 | Escherichia coli | P0ABP8 | - |
- |
2.4.2.1 | Escherichia coli | P45563 | - |
- |
2.4.2.1 | Helicobacter pylori | A0A518Y5Z2 | multifunctional fusion protein | - |
2.4.2.1 | Homo sapiens | P00941 | - |
- |
2.4.2.1 | Pectobacterium carotovorum | - |
- |
- |
2.4.2.1 | Plasmodium falciparum | Q8I3X4 | - |
- |
2.4.2.1 | Plasmodium lophurae | - |
- |
- |
2.4.2.1 | Thermus thermophilus | - |
- |
- |
EC Number | Reaction | Comment | Organism | Reaction ID |
---|---|---|---|---|
2.4.2.1 | purine ribonucleoside + phosphate = purine + alpha-D-ribose 1-phosphate | molecular mechanism of catalysis involving protonation of the purine ring position N7, open and closed active site conformations, overview | Escherichia coli | |
2.4.2.1 | purine ribonucleoside + phosphate = purine + alpha-D-ribose 1-phosphate | the trimeric PNPs show that there is no acidic residue in the vicinity of the purine ring N7, only the side-chain of Asn243 (Asn246 in Cellulomonas PNP) is found there. Moreover, in the latter structure, Asn246 interacts with purine through a water molecule, questioning the protonation mechanism in the catalysis. The molecular mechanism of catalysis of trimeric PNPs involves either protonation of the purine ring N7, or a negatively charged purine intermediate stabilized by hydrogen bonds of purine N(7) with Asn243, or of the purine N1H with Glu201 (Glu204 in Cellulomonas PNP). Ordered water molecules provide a proton transfer bridge to O6 and N7 and permit reversible formation of these hydrogen bonds. The alternative mechanism assumes a negatively charged purine ring in the transition state stabilized by a hydrogen bond from Asn243 to purine ring N7. Key catalytic role of Glu204 | Cellulomonas sp. | |
2.4.2.1 | purine ribonucleoside + phosphate = purine + alpha-D-ribose 1-phosphate | the trimeric PNPs show that there is no acidic residue in the vicinity of the purine ring N7, only the side-chain of Asn243 is found there. The molecular mechanism of catalysis of trimeric PNPs involves either protonation of the purine ring N7, or a negatively charged purine intermediate stabilized by hydrogen bonds of purine N(7) with Asn243, or of the purine N1H with Glu201. Ordered water molecules provide a proton transfer bridge to O6 and N7 and permit reversible formation of these hydrogen bonds. The alternative mechanism assumes a negatively charged purine ring in the transition state stabilized by a hydrogen bond from Asn243 to purine ring N7. Key catalytic role of Glu201 | Bos taurus | |
2.4.2.1 | purine ribonucleoside + phosphate = purine + alpha-D-ribose 1-phosphate | the trimeric PNPs show that there is no acidic residue in the vicinity of the purine ring N7, only the side-chain of Asn243 is found there. The molecular mechanism of catalysis of trimeric PNPs involves either protonation of the purine ring N7, or a negatively charged purine intermediate stabilized by hydrogen bonds of purine N(7) with Asn243, or of the purine N1H with Glu201. Ordered water molecules provide a proton transfer bridge to O6 and N7 and permit reversible formation of these hydrogen bonds. The alternative mechanism assumes a negatively charged purine ring in the transition state stabilized by a hydrogen bond from Asn243 to purine ring N7. Key catalytic role of Glu201 | Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.2.1 | blood | high PNP level | Homo sapiens | - |
2.4.2.1 | erythrocyte | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.1 | 1,N6-ethenoadenosine + phosphate | i.e. 3-beta-D-ribosylimidazo[2,l-i]purine | Escherichia coli | 1,N6-ethenoadenine + beta-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | 1-methyladenosine + phosphate | - |
Escherichia coli | 1-methyladenine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | 1-methylguanosine + phosphate | - |
Escherichia coli | 1-methylguanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | 2,6-diamino-8-azapurine + alpha-D-ribose 1-phosphate | PNP mutant D204N | Bos taurus | N7-D-ribosyl-2,6-diamino-8-azapurine + phosphate | - |
r | |
2.4.2.1 | 2,6-diamino-8-azapurine + alpha-D-ribose 1-phosphate | - |
Bos taurus | N8-D-ribosyl-2,6-diamino-8-azapurine + phosphate | - |
r | |
2.4.2.1 | 2,6-diamino-8-azapurine + alpha-D-ribose 1-phosphate | PNP mutant D204N | Bos taurus | N9-D-ribosyl-2,6-diamino-8-azapurine + phosphate | - |
r | |
2.4.2.1 | 6-mercaptopurine-2'-deoxyriboside + phosphate | - |
Escherichia coli | 6-mercaptopurine + 2-deoxy-alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | 8-azaguanine + alpha-D-ribose 1-phosphate | - |
Escherichia coli | 8-azaguanosine + phosphate | - |
r | |
2.4.2.1 | 8-azaguanosine + phosphate | - |
Escherichia coli | 8-azaguanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | 8-azaguanosine + phosphate | - |
Homo sapiens | 8-azaguanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | 9-beta-D-arabinosyl-2-fluoroadenine + phosphate | i.e. fludarabine | Escherichia coli | 2-fluoroadenine + beta-D-arabinose 1-phosphate | - |
r | |
2.4.2.1 | adenosine + phosphate | - |
Escherichia coli | adenine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | - |
Thermus thermophilus | guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | - |
Bacillus cereus | guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | - |
Pectobacterium carotovorum | guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | - |
Plasmodium lophurae | guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | - |
Cellulomonas sp. | guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | - |
Bos taurus | guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | - |
Escherichia coli | guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | - |
Plasmodium falciparum | guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | - |
Homo sapiens | guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | guanosine + phosphate | - |
Helicobacter pylori | guanine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | - |
Thermus thermophilus | hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | - |
Bacillus cereus | hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | - |
Pectobacterium carotovorum | hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | - |
Plasmodium lophurae | hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | - |
Cellulomonas sp. | hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | - |
Bos taurus | hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | - |
Escherichia coli | hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | - |
Plasmodium falciparum | hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | - |
Homo sapiens | hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | inosine + phosphate | - |
Helicobacter pylori | hypoxanthine + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | additional information | hexameric PNPs accept as substrates many nucleoside analogues with various modifications in the purine ring, with an important exception of 7-deaza nucleosides. N7-Methylated guanosine, inosine and adenosine are unusual fluorescent substrates of both trimeric and hexameric PNPs | Escherichia coli | ? | - |
- |
|
2.4.2.1 | additional information | N1-methylated guanosine, inosine, and adenosine derivatives are selective substrates for hexameric PNP from Escherichia coli. Hexameric PNPs accept as substrates many nucleoside analogues with various modifications in the purine ring, with an important exception of 7-deaza nucleosides. N7-Methylated guanosine, inosine and adenosine are unusual fluorescent substrates of both trimeric and hexameric PNPs. Escherichia coli PNP converts pro-drugs, which are relative nontoxic purine nucleosides (for example 6-methyl purine 2'-deoxynucleoside or fludarabine), to their respective purine analogs (here, to 6-methylpurine and 2-fluoroadenine, respectively), which are very potent, toxic drugs. Enzymatic ribosylation of 8-azapurines, overview. Isoadenosine (3-beta-D-ribosyl-adenine), is, unlike the parent adenosine, a quite good substrate for mammalian and bacterial PNP. Ribosylation of tri-cyclic nucleobase analogues and phosphorolysis | Escherichia coli | ? | - |
- |
|
2.4.2.1 | additional information | nicotinamide riboside is a substrate of trimeric PNPs because it mimics 6-keto/N1H arrangement of 6-oxopurine nucleosides and 8-azaguanine. For trimeric PNP, the proton at the purine position N1 is required for catalysis. N7-Methylated guanosine, inosine and adenosine are unusual fluorescent substrates of both trimeric and hexameric PNPs. No activity with pro-drugs 6-methyl purine 2'-deoxynucleoside or fludarabine (9-beta-D-arabinosyl-2-fluoroadenine). Enzymatic ribosylation of 8-azapurines, overview. Isoadenosine (3-beta-D-ribosyl-adenine), is, unlike the parent adenosine, a quite good substrate for mammalian and bacterial PNP. Ribosylation of tri-cyclic nucleobase analogues and phosphorolysis | Homo sapiens | ? | - |
- |
|
2.4.2.1 | additional information | the hexamric PNP binds adenosine but it does not catalyze its phosphorolysis | Thermus thermophilus | ? | - |
- |
|
2.4.2.1 | additional information | the trimeric PNP binds adenosine but it does not catalyze its phosphorolysis | Cellulomonas sp. | ? | - |
- |
|
2.4.2.1 | nicotinamide riboside + phosphate | - |
Escherichia coli | nicotinamide + alpha-D-ribose 1-phosphate | - |
r | |
2.4.2.1 | xanthosine + phosphate | - |
Escherichia coli | xanthine + alpha-D-ribose 1-phosphate | - |
r |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
2.4.2.1 | homodimer | the enzyme is an exception since PNPs are almost all homotrimers or homohexamers | Pectobacterium carotovorum |
2.4.2.1 | homohexamer | - |
Escherichia coli |
2.4.2.1 | homohexamer | trimer of dimers | Escherichia coli |
2.4.2.1 | homopentamer | the enzyme is an exception since PNPs are almost all homotrimers or homohexamers | Plasmodium lophurae |
2.4.2.1 | homotetramer | the enzyme is an exception since PNPs are almost all homotrimers or homohexamers | Bacillus cereus |
2.4.2.1 | homotrimer | - |
Bos taurus |
2.4.2.1 | homotrimer | - |
Homo sapiens |
2.4.2.1 | homotrimer or homohexamer | the hexamer is a trimer of dimers | Thermus thermophilus |
2.4.2.1 | homotrimer or homohexamer | the hexamer is a trimer of dimers | Cellulomonas sp. |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.2.1 | DeoD | - |
Escherichia coli |
2.4.2.1 | PNP | - |
Thermus thermophilus |
2.4.2.1 | PNP | - |
Bacillus cereus |
2.4.2.1 | PNP | - |
Pectobacterium carotovorum |
2.4.2.1 | PNP | - |
Plasmodium lophurae |
2.4.2.1 | PNP | - |
Cellulomonas sp. |
2.4.2.1 | PNP | - |
Bos taurus |
2.4.2.1 | PNP | - |
Escherichia coli |
2.4.2.1 | PNP | - |
Plasmodium falciparum |
2.4.2.1 | PNP | - |
Homo sapiens |
2.4.2.1 | PNP | - |
Helicobacter pylori |
2.4.2.1 | PNP-II | - |
Escherichia coli |
2.4.2.1 | punA | - |
Cellulomonas sp. |
2.4.2.1 | xanthosine phosphorylase | - |
Escherichia coli |
2.4.2.1 | XAP | - |
Escherichia coli |
2.4.2.1 | xapA | - |
Escherichia coli |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.4.2.1 | 0.000000005 | - |
SerMe-immucillin-H | pH and temperature not specified in the publication | Homo sapiens | |
2.4.2.1 | 0.000000009 | - |
DADMe-immucillin-H | pH and temperature not specified in the publication | Homo sapiens | |
2.4.2.1 | 0.000000009 | - |
DATMe-immucillin-H | pH and temperature not specified in the publication | Homo sapiens | |
2.4.2.1 | 0.000000023 | - |
DADMe-immucillin-H | pH and temperature not specified in the publication | Bos taurus | |
2.4.2.1 | 0.000000058 | - |
immucillin-H | pH and temperature not specified in the publication | Homo sapiens | |
2.4.2.1 | 0.0000044 | - |
DFPP-DG | pH and temperature not specified in the publication | Bos taurus | |
2.4.2.1 | 0.0000135 | - |
9-(3-pyridylmethyl)-9-deaza-guanosine | pH and temperature not specified in the publication | Homo sapiens | |
2.4.2.1 | 0.0003 | - |
6-methylformycin A | pH and temperature not specified in the publication | Escherichia coli | |
2.4.2.1 | 0.005 | - |
formycin B | pH and temperature not specified in the publication | Escherichia coli | |
2.4.2.1 | 0.1 | - |
formycin B | pH and temperature not specified in the publication | Homo sapiens |
EC Number | Organism | Comment | Expression |
---|---|---|---|
2.4.2.1 | Escherichia coli | Escherichia coli PNP-II (xanthosine phosphorylase) is inducible by xanthosine | up |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.4.2.1 | evolution | in some organisms, like Escherichia coli, two distinct forms of PNP exist, with markedly different structure and substrate specificity. The second form, the so-called E. coli PNP-II, is sometimes referred to as xanthosine phosphorylase, since it is inducible by this nucleoside, but its specificity is not limited to this compound, and includes guanosine, inosine and nicotinamide riboside | Escherichia coli |
2.4.2.1 | evolution | in some organisms, like Escherichia coli, two distinct forms of PNP exist, with markedly different structure and substrate specificity. The second form, the so-called Escherichia coli PNP-II, is sometimes referred to as xanthosine phosphorylase, since it is inducible by this nucleoside, but its specificity is not limited to this compound, and includes guanosine, inosine and nicotinamide riboside | Escherichia coli |
2.4.2.1 | evolution | the homodimeric PNP from Ervinia carotovora cannot be assigned to the two described PNP classes, trimeric and hexameric PNPs | Pectobacterium carotovorum |
2.4.2.1 | evolution | the homotetrameric PNP from Baccilus cereus cannot be assigned to the two described PNP classes, trimeric and hexameric PNPs | Bacillus cereus |
2.4.2.1 | evolution | the pentameric PNP from Plasmodium lophurae cannot be assigned to the two described PNP classes, trimeric and hexameric PNPs | Plasmodium lophurae |
2.4.2.1 | evolution | the PNP from Cellulomonas sp. cannot be assigned to the any of two described PNP classes, trimeric and hexameric PNPs | Cellulomonas sp. |
2.4.2.1 | evolution | the PNP from Thermus thermophilus cannot be assigned to the any of two described PNP classes, trimeric and hexameric PNPs | Thermus thermophilus |
2.4.2.1 | malfunction | substrate specificity of trimeric and hexameric PNPs may be changed by mutations of the crucial active site amino acids, namely Asp in hexameric PNPs and Asn in trimeric PNPs | Thermus thermophilus |
2.4.2.1 | malfunction | substrate specificity of trimeric and hexameric PNPs may be changed by mutations of the crucial active site amino acids, namely Asp in hexameric PNPs and Asn in trimeric PNPs | Cellulomonas sp. |
2.4.2.1 | malfunction | substrate specificity of trimeric and hexameric PNPs may be changed by mutations of the crucial active site amino acids, namely Asp in hexameric PNPs and Asn in trimeric PNPs | Bos taurus |
2.4.2.1 | malfunction | substrate specificity of trimeric and hexameric PNPs may be changed by mutations of the crucial active site amino acids, namely Asp in hexameric PNPs and Asn in trimeric PNPs | Escherichia coli |
2.4.2.1 | malfunction | substrate specificity of trimeric and hexameric PNPs may be changed by mutations of the crucial active site amino acids, namely Asp in hexameric PNPs and Asn in trimeric PNPs | Homo sapiens |
2.4.2.1 | physiological function | Escherichia coli PNP converts pro-drugs, which are relative nontoxic purine nucleosides (for example 6-methyl purine 2'-deoxynucleoside or fludarabine), to their respective purine analogues (here, to 6-methylpurine and 2-fluoroadenine, respectively), which are very potent, toxic drugs | Escherichia coli |